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RCA. Failure of RV branch reperfusion was associated with lack of early
recovery of RV wall motion (baseline RVFW motion 3.7 + 0.4 to 3.3 + 0.7
at 1 hour and 3.1 + 0.6 at 1 day) and global RV performance (baseline RV
FAC 24 + 6% to 25 + 7% at 1 hour and 27 + 7% at 1 day). Furthermore,
in 5 of these 7 (71%) pts, cardiogenic shock developed despite intact LV
function (mean LVEF 49 + 3%) leading to early death within 48 hours in all
such cases. These observations demonstrate that primary PTCA resulting
in successful RV branch reperfusion leads to prompt and complete recovery
of RV performance, and influences clinical outcome. In contrast, inability to
restore flow to the RV branches is associated with lack of recovery of RV
function and poor clinical outcome. (’p < 0.05).
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Thrombolysis
C.McLean, M. Rizzo, K. Ryan, C. McCabe, C. Cannon, M. Gibson, for the
TIMI 10A investigators. West Roxbury VAMedical Center and Brigham &
Women’s Hospital, Boston, MA, USA
The presence of abnormally slow flow in non-culprit arteries after thrombol-
ysis has previously been described, & the goal was to determine the rela-
tionship between non-culprit flow &other angiographic variablea. The frames
required fordyeto reach standardized distal landmarks were munted, & LAD
frame counts were divided by 1.7 to correct for their longer length (Corrected
TIMI Frame Count or CTFC). The non-culprit CTFC improved from 32.5 +
18.1 frames (n= 60) at 60 min. after TNK administration in TIMI IOA to 29.4
+ 13.6 (n = 146) frames at 90 min. (p = 0.006), & the 90 min. value was
slower than that previously reported for normal arteries in the abence of
acute Ml (21.0 + 3.1, n = 78, p < 0.0001). Failure to achieve TIMI 3 flow
in the culprit artery waa associated with alower non-culprit flow at 90 min.:
25.5 + 11.1 (n = 69) vs 33.1 + 14.8 frames (n = 75) (p < 0.001). Increased
normal reference segment diameters in both the non-culprit (p = 0.007) &
culprft (p = 0.03) arteries were both correlated with slower 90 min. non-culprit
CTFCS.Left dominant systems were associated with slower non-culprit flow
at 90 min.: 36.2 + 16.3 (n = 20) vs 28.8 + 13.3 (n = 106), p = 0.03. Increased
length of the artery distal to the culprit stenosis was correlated with slower
nomculprit flow (p = 0.04) as was reduced stroke volume (p = 0.04) at 90
min. Cone/uaiona:These obsewations confirm the presence of delayed flow
in non-culprit arteriea at 90 minutes after thrombolysis which appeara to be
associated with both slower flow in the culprit artery & increased myocar-
dial territory supplied by the culprit artery (i.e. increased arterial diameter&
increased artery length distal to the culprit artery stenosis).
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Intrscoronary Thrombus in Pstisnts Presenting to a
Emergency Department with Possible Acute
Coronary Syndromee
A.F. Sonel, Y. Gawad, L. Perkins, R.L. Wilensky. Knsnner?hrstitute of
Cardiology Indianapolis, USA, Universifyof Pennsylvania Medical Centec
Phi/ade/pfria, USA
Varying degrees of intracoronary thrombus formation and myocyte destruc-”
tion occur in unstable angina (UA) and myocardial infarction (Ml). A panel of
markers were determined in 99 patients presenting with chest pain thought
to be due to possible acute corona~ ischemia. This paneI included serum
for troponin I (Tnl), myosin light chain 1 (MLCI), myoglobin (Mb) and spot
urine for fibrinopeptide A (FPA) upon presentation and at 4 hours. Patients
discharged from the Emergency Department were seen within 46 hours. The
final diagnoses determined independent of the study markers were: Ml 11
patients, UA31 patients, stable angina ornon-cardiac chest pain 57patients.
Results were (Sensitivity, positive predictive value, negative predictive value
and significance, respectively):
Ml Ml 0, 11A
c19465 Less Myocardisl but More Cerebral Ischemic Evente
in African Americans Than Caucasians With Acute
Coronary Syndromes: Results from GUSTO-II
D.J. Moliterno, C.A. Asher, R.M, Califf, K,A. Clark, A.D. Guerci, E.J. Topol,
for the GUST041B Investigators. The C/eve/and C/irricFoundation,
C/eve/and, OH, USA
Several reports have identified differences between African Americans and
Caucasians concerning risk factors and prognosis related to atherosclerotic
heart disease, however, data comparing these races with acute coronary
syndromes is very limited. Thus, we prospectively collected data regarding
outcome and race in the GUSTO-IIB trial which compared outcomes among
patients with acute coronary syndromes randomized to heparin or hirudin.
The study included 7496 Caucasians and 245 African Americans with ECG
evidence of unstable angina or Non-Q-wave Ml. Compared to Caucesiana,
African Americans were younger (57.2 vs 65.9 yrs) but .sIgnificantly more
often female, smokers, hypertensive, and diabetic. Despite this, and pre-
senting later for treatment (6.3 vs 5.0 hrs), African Americans had a similar
mortality rate at 30 days (2.9% vs 2.7%). Among suwivors, while African
Americans were more likely to have cerebral ischemia (stroke), they were
less likely to have recurrent myocardial ischemia, refractory ischemia, or
Ml (table), African Americans were also more likely to undergo PTCA than
CABG. These findings confirm important racial differences among patients
with acute coronary syndromes, and the independent effect of race is being
quantified in a multivariable model.
30-DsYEvent AfricanAmerican (%) Caucaaian(%) p-value
Ml 3.s &2 0.132
Refractoy iachemia 6.3 24.1
CABG
<0.001
18.9 29.0
Stroke
0.034
6.5 2,0 0,035
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m Patients with Ml: When Should You Take the Next
ECG Aftar Lytics?
M.W. Krucoff, CL. Green, K.M. Trollinger, J.E. Pope, R.A. Hanington,
C.B. Granger, E.M. Ohman, K. Neuhaus, E.J. Topol, R,M. Califf. Duke
University Medkel Center Durham, NC, LISA
ST-aegment recovery analysis from continuous 12-lead ECG monitoring has
beencorrelated with infarct artery patency,drug efficacy and ciinicaloutcome.
Most hospitals do not yet have continuous 12-lead monitoring capability. To
identify the temporal landmarks associated with key ECG changes, all 544
analyzable continuous 12-lead ECG monitor (ST-100, Mortara Instrument)
studies from AMI patients treated in the TAMI-9 (n = 196), DUCCS-2 (n = 32),
GUSTO-1(n= 217) and IMPACT-I(n= 99) trials were examined. Key ECGS
included: PEAK (ECG with most ST deviation); T50 (the first ECG showing
50% recoverysuggesting reperfusion); and STEADY (the first ECG ahowing
50’%recoverythat ia atable for >4 hours). Key ECGSwere timed from: onset
of chest pain (CP time); time of the first diagnostic ECG (DX time); and onset
of Iytic therapy (RX time). Results, as median (25th, 75th %ile) in minutes
were:
PEAK ST T50 STEADY ST
CP TIME 166 (110, 245) 209 (146, 291) 314 (219, 426)
DX TIME 55 (o, 102) 9s (64, 144) 184 (114, 316)
RX TIME 7.5 (–33, 42) 42 (13, 76) 1!23(61, 241)
Thus, despite considerable variability from patient to patient, the sampling
from an acute Ml population is: 1) about 60 minutes after the first diagnostic
ECG for PEAK ST changes 2) about 40 minutes after onset of Iytic therapy
for firet evidence of reperfusion, and 3) about 120 minutes after onaet of Iytic
therapy for stable reperfuaion.
Tnl 91,100,99 p <0,001 45,77, 100 p <0,001
MLC1 91,21,98 p= 0.003 64,56,71 p = 0,006
Mb 91,50,99 p<0.001 36,75,66 p <0.001
FPA 64,30,95 p= 0.003 36,65,66 p = 0.024
Any Markar 100,21,100 p <0.001 61,61,63 p <0,001
Markers of intramronary thrombus formation and myocyte injury show a
high negative predictive value and can differentiate UA and Ml patients from
other ceuaea of chest pain. Such a panel may impact initial riak assessment
and triage optiona.
n T,M,10946-19 Flow After Adjunctive & Rescue PTCA in TIMI 4 &
M. Gibaon, C. McLean, M. Rizzo, K. Ryan, C. Cannon, E. Braunwald, for the
TIMI 4 and TIMI 10A&B Investigators. Brigham and Women’s Hospita/,
Boston MA, USA
The freme$ for dye to reach standardized distal landmarks were counted to
arrive at the Corrected TIMI Frame Count (CTFC, an index of flow) before&
after adjunctive or reacue PTCA following thrombolysis in the TIMI 4 (TPA,
APSAC), 10A (TNK), & IOB (TNK, TPA) triala:
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Pra PTCA TIMI HOW Pre PTCA CTFC Post PTCA CTFC Delta CTFC
TIMI 0/1 Occluded 28.5 + 16.5, n = 70 Nonapplicable
TIMI 2 63.2 + 37.0, n = 25 26.3+ 17.8, n = 19 43.7+42.6, n = 19
TtMl 3 30.6 + 9.9, n = 19” 20.5+ 11.5, n =16 10.3* 12.8, n = 16
TtMl 2 or3 49.1 & 32.6, n = 44 23.5& 15.1, n =37 27.4 k 35.6, n =37
Previously we reported that normalarteriesin the absence of acute Ml
have a CTFC of 21.0 + 3.1 (n = 78). PTCA of arteries with TIMI 3 Flow
reatored a normal CTFC (20.5 vs 21.0, p = NS). Adjunctive PTCA of arteries
with TIMI 2 flow improved flow by 43.7 frames (p = 0.0006) but did not restore
a normal CTFC (26.3 vs 21.0 p = 0.01) and approximates that repotted for
non-culprit arteries in acute Ml (25.5 frames). Likewise, rescue PTCAof TIMI
0/1 flow did not restore a normal CTFC (28.5 vs 21.0, p = 0.0001). Slower
Pra PTCA CTFCS were correlated with greeter improvements in CTFC (r =
0.91, p -=0.0001). Conclusions: PTCAof the residual stenosis in arteries with
TIMI 3 flow atter thromboiysis results in normal flow (CTFC = 21). Although
PTCA of the reeidual stenosis in arteries with TIMI 2 flow greatly improves
flow, the flow remains peraietently slowed by 5 frames (20% > normal). This
5 frame delay is similar to that observed in non-culprit arteries in acute Ml,
& may reflect a peraietent abnormality in microvascular reeistence.Whether
PTCA of atteries with TIMI 2 flow improves clinical outcomea remains to be
determined. -
m94620 Clinical Usefulness of Dual SPECT Imaging ofTc.ggm ~stamibi and 1231-IPPA for Predicting
Myocardial Viability After Thrombolyaed
Myocardial Infarction
M. Pence, S. Romano, S. Rosanio, M. Tocchi, A. Vitarelli, A. Dagianti,
M. Benci, F. Scopinero 1,F. Fedele, A. Dagianti. Dpt. of Cardiovascular and
Respiretory Sciences, “Le Sepienza” University Rome, /ta@,1Dpt. of
Experimental Medicine, “La Sapienza” Unive~ity Rome, Itafy
There ie controversy on the value of Tc-99m Sestamibi SPECT (MIBI) for
detection of myocerdial viability. This study”wae performed to investigate
the ability of MIBI in conjunction with 1231-Phenylpentadaoenoicacid (IPPA)
in identifying dysfunctional but viable myocardium after earty (<4 hours)
thromlmlytic treatment for myocerdial infarction (Ml). We compared, in mr-
responding myocerdial segments, perfusion and metabolic patterns in 22
petienta with firat uncomplicated Ml (16 males, age 36t064 yra) after4 * 1.5
daya from symptoms oneet. Myocardial viability wea defined by the discrep-
ancy bStWSenparfueion defect on MIBI and fatty acid metabolism on IPPA
SPECT:dual SPECTimage aequieition in 3 projactione (anterior,45Qand 71Y
tAO) wea carried out at 60 min from MIBI and 30 min from IPPA injections.
The Ieftventricle weadivided into 9 eagmente (apex, 4distel and4besal seg-
mente) and analyzed using a quantitative uptake score as normal = 1, mild
reduction =2, eevere reduction= 3, defect =4. Toassessfunctional recovery
of eaynergic areas, all patients underwent 2D achocardiography evaluating
wall motion score index (WMSI) and ejeetion fraction (EF) on the same day
of radionuclide imaging and 8 weeke after: improvement was defined as
decrease of WMSI ? 1. WMSI at baeeline well correlated with IPPA score (r
= o.i’6, p < 0.01) while did not with MIBI score (r= o.61, P = ne). The lppA
score wae significantly larger than the MIBI score (6.7 +3.1 vs 3.4+2.1, p <
0.01) The discrepancy between IPPA and MIBI was significantly correlated
with the extent of the improvement of WMSI (r= 0.66, p < 0.01) and of EF (r =
0.60, p c 0.01) at 6 weeks. In conclusion, the identification by dual MIBI and
IPPA SPECT of segmental metabolism-perfusion mismatch (possibly due
to stunning phenomenon after thrombolysad myooerdial infarction) predicts
myoeardial viability and later recovery.of left ventricular contractile function.
D94621 Pereietent Myoglobin Elevetion ia Associated withSlower Flow in Patent Culprit Afteries Following
Successful Thrombolysis
M. Rizzo, 1.Doteni, C. McLean, K. Ryan, C. McCabe, M. Tanasijevic,
C. Cannon, M. Gibson, E. Braunwald, for the TIMI IOA Trialists. Wast
Roxbwy VAMedical Center and Brfgham & Women’s Hospital, Boston, MA,
USA
This study examined the relationship between the release of myoglobin and
blood flow in patent culprit atieries at 90min. following thrombolyais with TNK
in TIMI loA. The frames required for dye to reach standard landmarks were
counted to arrive at the Corrected TIMI Frame Count (CTFC), a previously
described index of coronary blood flow. Slower 90 min. flow (i.e. higher
CTFCS)was correlated with higher12 hour(r= 0.66, p = 0.13331,n = 34), &
higher24 hourmyoglobinlevels(r= 0.65, p = 0.0001, n = 35) (24 hourdata
showninfigure)andtendedto behigherat 6 houra(r= 0.32, p =0.056). The
24 hr. mean myoglobin of pta. with slow flow (CTFC z 40) (116.5 + 65.5, n
=9) did not differ from that of pts. with a closed artety (137.8 & 156.9, n = 5,
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P= NS)butwashigherthanpta.withmore rapid90 min.flow (CTFC c 40)
(55.5 + 4.7, n = 26, p = 0.001).
=“’”l. ....... r -0.64.. .. p< 0.0901. “-*~ -%.% “. . .
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Conclusions: Slower flow in patent culprit arteries at 90 min. folIowing
thrombolysis is associated with a persistent elevation of myoglobin at 12 and
24 hra which approximates that observed in occluded arteriee, possibly as a
result of delayed washout.
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A. Huizenga, W.R.M. Aengevaeren, T. van der Werf, F.W.A.Verheugt.
Depetiment of Cardiology, University Hospital Nijmegen, The Netherlands
TIMI frame count (TFC), presented as a simple, reproducible quantitative
index of coronary blood flow, is the numbarof frames needed for the appear-
ance of the front of the contrast bolus !O reach predefine distal landmarks.
From the indicetordilution thaory follows, however, that appearance time has
only a weak relation with flow. Mean transit time (MTT), on the other hand,
ie fundamentally related to myooardial flow. The MTT-method has been suc-
cessfully teeted against direct flow measurements in dogs. Therefore, we
coneiderad a comparison between the simply applicable TFC and laborious
MTT ueeful.
We atudisd 109 coronary arteriograms of atable patienta, previously in-
cluded into cholesterol lowering trials, from whom the MU’S were alrasdy
aseessed. TFC was determined by 2 independent angiogrephera, blinded
to the MTT date. If this reaulted in a difference of >5 framee, oonsensue
was reached with a third obaewer. MU, from injection site to a myocar-
dial area of interest, was assessed by digital subtraction angiography with
videodensitometric analyses of the time couffie of the contrast.
Linear regression analysis between TFC (frames) and MU (see) on all
arterial and on LAD, LCX and RCA territories separately showed correlation
coefficients of 0.12, 0.20, 0.26 and 0.31, respectively. These poor reeultadid
not change substantially by excluding thoee observations, in which there was
a difference of >5 frames between observera (about 20% of all oases).
Conclusion: Ae expected, TFC does not seem to reflect myocerdial flow,
as measured by MU, instable coronary patients. TFC, therefore, is probably
of limited value in the quantitation of myocerdial blood flow restoration in
acute myocardial infarction.
1946-231Translumina,EfiraCtiOnAthereCtomy.va.Balloon
angioplasty in Acute Ischemic Syndromes (TOPIT):
Hospital outcome and six-month status
T.L. Schreiber, B.M. Kaplan, M.L. Gregory, C.L. Brown, Ill, D.G. Rizik,
R.R. Masden, A. Brahimi, W.W. O’Neill. William Beaumont Hospital, Royal
Oak, Ml, USA, St. John Hospital, Detroit, Ml, USA
The TOPIT Trial is a randomized, multicanter study comparing the use
of tmnsluminal extraction atherectomy (TEC) veraus balloon angioplaaly
(PTCA) in native veesels for clinical situation which are associated with in-
traooronaty thrombue. We hypothesize that pretreatment with TECenhances
outcome during percutaneous revascularization for high rick patiente with
acute ischemic ayndromes. 115patients (mean age 60.Ojwere randomized
to TEC while 135 patients (mean age 56.7 year) to PTCA. Clinical indioe-
tiona included pnmaty reperfusion for acute myocardial infarction (31.6f%),
unatable angina (30.8%), post-infarction angina (24.8%), and thromboifiic
failure (10%),
Outcomes were:
TEC 115 PTCA 135 0 value
Death in hospital 1 (0.67”A) o NS
EmergentCABG 1 (0.s7%) 1 (0.s7%) NS
Emergent PTCA 5 (4,35%) 5 (3.70”/0) NS
Initial% stenosis 75.2 + 16.7 76.6 & 17.5 NS
Final ‘A stenoais 26.2 & 1S,4 27.6 + 16.9 NS
Final% thrombosis 6“/0 3% NS
3x increase CPK 1.6.3% 5.69% o.oa2
